Loading...
Rare Disease Focus Will Face Intense Rivalry Yet Value Persists
AnalystLowTarget's Fair Value
US$11.00
24.8% undervalued intrinsic discount04 Sep
US$8.27
1Y
1.7%7D
-2.4%1Y
1.7%7D
-2.4%Edit anytime before Aug 30 10:22 PM. Then post Updates to your followers.